Olmesartan Medoxomil And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 67877-451

5 FDA label images from Ascend Laboratories, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Olmesartan Medoxomil And Hydrochlorothiazide (NDC 67877-451). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Olmesartan-str-1 (Olme Olmesartan Str 1)

Olmesartan-str-1 (Olme Olmesartan Str 1)
Chemical structure diagram of the active ingredient Olmesartan Medoxomil showing its molecular components and bonding relationships.*
FDA Label Image

Hctz-str-2 (Olme Hctz Str 2)

Hctz-str-2 (Olme Hctz Str 2)
Chemical structure diagram of Olmesartan Medoxomil and Hydrochlorothiazide, showing molecular bonds and atom groupings typical for these active ingredients in the drug formulation.*
FDA Label Image

Olme-hctz-20-125mg-90-tablets-a (Olme Hctz 20 125mg 90 Tablets A)

FDA Label Image

Olme-hctz-40-125mg-90-tablets-a (Olme Hctz 40 125mg 90 Tablets A)

FDA Label Image

Olme-hctz-40-25mg-30-tablets-a (Olme Hctz 40 25mg 30 Tablets A)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.